Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering. The company listed 5,175,000 units at 58 cents each.
Bone Biologics, a company focused on spine fusion products, announced a $2 million public offering. The public offering includes 781,251 shares of its common stock for $2.56 per share.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
